Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,721.18
(
0.29%
)
News Focus
News Focus

Replies to post #5458 on GTC Biotherapeutics (fka GTCB)

Replies to #5458 on GTC Biotherapeutics (fka GTCB)
icon url

dewophile

11/02/07 10:34 AM

#5459 RE: anotherbiotechguy #5458

agreed
as far as I know there is no IP barrier to adding an N-glycosylation signal sequence to the construct (I perused Amgen's patent years ago and it was fairly narrow and specific to epo)